SynthesisBMC cardiovascular disorders2026
Red blood cell distribution width-albumin ratio as predictor of mortality in patients with cardiac disease: a systematic review and meta-analysis.
Synthesis in BMC cardiovascular disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
objectiveThis study aims to investigate the utility of red blood cell distribution width-albumin ratio (RAR) for predicting mortality in patients with cardiac diseases.
methodsPubMed, Scopus, Embase, and Web of Science databases were systematically searched for studies reporting the association between RAR and mortality in cardiac patients. The search limits were from inception of databases to 20th December 2024. Meta-analysis was conducted for short-term (up to 30 days) and long-term (> 30 days) mortality.
resultsThe analysis of the eight eligible studies showed that per unit increase in RAR [odds ratio (OR): 1.31 95% confidence intervals (CI): 1.16, 1.49 I
conclusionsRAR can be a potential biomarker for predicting mortality in patients with cardiac disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.